[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Is your scope of Wholesale Distribution Authorisation (WDA) out of date?

Is your scope of Wholesale Distribution Authorisation (WDA) out of date?

by Kimberley Peck | Aug 23, 2022 | Blog, MHRA, WDA(H)

Is your scope of Wholesale Distribution Authorisation (WDA) out of date? – Are you aware that the Wholesale Distribution Authorisation (WDA) categories have changed?

Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance

Import Licensed Human Medicine(s) to the United Kingdom (UK) – Guidance

by Amelia Holmes | Jul 13, 2022 | Blog, MHRA, WDA(H), WDA(H)

Import Licensed Human Medicine – Prior to importation of a licensed medicine applications for the relevant Licence(s) must be completed and submitted which may include one or more of the following:

Licences for Medicines Wholesale – The Basics in 2 minutes!

Licences for Medicines Wholesale – The Basics in 2 minutes!

by Sally Cox | Feb 4, 2022 | Blog, RP Forum, WDA(H)

Licences for Medicines Wholesale – Do you know what is required by you as a pharmaceutical wholesaler to fulfil legal requirements when working with medicines? Read on to learn the basics of why you need a WDA and where to find further information to accelerate your learning.

UK licensed medicinal products and the challenges of exporting

UK licensed medicinal products and the challenges of exporting

by Steven Hewison | Dec 16, 2021 | Blog, Consultancy, Export, MHRA, WDA(H), WDA(H)

UK licensed medicinal products and the challenges of exporting – Many clients contact us for information and help on expanding the scope of their WDA license to include the export UK licensed medicinal products without necessarily understanding the challenges of exporting UK licensed medicinal products.

WDA(H) & Import – New Guidelines:

WDA(H) & Import – New Guidelines:

by Sally Finlayson | Jul 21, 2021 | Blog, Brexit, GDP/RP, MHRA, RP, Training, WDA(H)

Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi

Export & WDA(H) – Updated Guidelines:

Export & WDA(H) – Updated Guidelines:

by Sally Finlayson | Jul 14, 2021 | Blog, Export Training, MHRA, WDA(H), WDA(H)

As Great Britain (GB) are no longer part of the European Union (EU) since the 1st of January 2021 exit date. It is essential to ensure all the necessary changes have been made to remain MHRA compliant.

« Older Entries
Next Entries »

Recent Posts

  • What are the main requirements for controlled drugs?
  • FSN for Zoll Powerheart G5 AEDs
  • Virtual Wholesaling

Upcoming Courses

  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025
  • GDP Audit Online Training on 17 July 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 23 July 2025 10:00 am
  • Export Online Training on 7 August 2025

MHRA Alerts & Recalls

Class 4 Medicines Defect Notification: Simvastatin 10mg Tablet, Crescent Pharma Ltd, EL(25)A/33
3 July 2025
Field Safety Notices: 23 to 27 June 2025
2 July 2025
Aurum pre-filled syringes phased introduction of new 10ml CONNECT syringe barrel: Importance of selecting compatible needle-free connectors to minimise the risk of syringe blockage (DSI/2025/02)
1 July 2025
Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd, EL(25)A/32
1 July 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow